Aseptic Meningitis after Amenamevir Treatment for Herpes Zoster in the First Branch of the Trigeminal Nerve.


Journal

Internal medicine (Tokyo, Japan)
ISSN: 1349-7235
Titre abrégé: Intern Med
Pays: Japan
ID NLM: 9204241

Informations de publication

Date de publication:
15 Sep 2022
Historique:
pubmed: 2 3 2022
medline: 17 9 2022
entrez: 1 3 2022
Statut: ppublish

Résumé

Amenamevir has been approved for the treatment of herpes zoster (HZ); however, its therapeutic efficacy against central nervous system (CNS) infection may be insufficient due to its low spinal fluid permeability. We herein report a case of aseptic meningitis in a 91-year-old Japanese man treated with amenamevir for HZ in the trigeminal nerve region. Several cases of CNS infection have been reported in patients receiving amenamevir treatment for HZ. Patients with CNS complications often have skin rashes near the trigeminal region. Thus, we should be alert for signs of CNS infection when administering amenamevir to patients with such rashes.

Identifiants

pubmed: 35228415
doi: 10.2169/internalmedicine.8581-21
pmc: PMC9556230
doi:

Substances chimiques

ASP2151 0
Antiviral Agents 0
Oxadiazoles 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2809-2811

Références

Am J Med. 1982 Jul 20;73(1A):186-92
pubmed: 7048911
J Infect. 2015 Sep;71(3):281-93
pubmed: 26073188
Neurology. 2008 Mar 11;70(11):853-60
pubmed: 18332343
J Dermatol. 2017 Nov;44(11):1219-1227
pubmed: 28681394
J Neurol Neurosurg Psychiatry. 2006 Aug;77(8):938-42
pubmed: 16844949
Rinsho Shinkeigaku. 2021 Apr 21;61(4):239-242
pubmed: 33762495
Rinsho Shinkeigaku. 2020 Dec 26;60(12):861-864
pubmed: 33229834
Expert Rev Anti Infect Ther. 2021 Nov;19(11):1415-1425
pubmed: 33853490
BMC Infect Dis. 2018 May 25;18(1):238
pubmed: 29801466
Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):693-706
pubmed: 29748821
Neurology. 2007 Mar 27;68(13):1069-73
pubmed: 17287447
Rinsho Shinkeigaku. 2019 Oct 26;59(10):641-645
pubmed: 31564701
Clin Infect Dis. 2008 Aug 1;47(3):303-27
pubmed: 18582201

Auteurs

Kazuhiro Itoh (K)

Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan.
Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Japan.

Yasuhiko Mitsuke (Y)

Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan.

Mami Wakahara (M)

Department of Dermatology, National Hospital Organization Awara Hospital, Japan.

Tatsuya Yoshioka (T)

Department of Ophthalmology, National Hospital Organization Awara Hospital, Japan.

Nozomi Otsuki (N)

Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan.

Yusuke Suzuki (Y)

Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan.

Chiyo Kiriba (C)

Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan.

Atsushi Kuwata (A)

Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan.

Ippei Sakamaki (I)

Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Japan.

Hiromichi Iwasaki (H)

Department of Infectious Diseases, Faculty of Medical Sciences, University of Fukui, Japan.
Division of Infection Control and Prevention, University of Fukui Hospital, Japan.

Hiroshi Tsutani (H)

Department of Internal Medicine, National Hospital Organization Awara Hospital, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH